 Diagnostic Healthcare Solutions Company Developing New Test Designed to Measure Neutralizing Antibodies of Deadly Opioid Fentanyl SAN DIEGO, CA, Jan. 17, 2023 GLOBE NEWSWIRE via NewMediaWire AXIM Biotechnologies, Inc. OTCQB: AXIM AXIM Biotech, AXIM or the Company, an international healthcare diagnostic solutions development company, announced today that it has filed a provisional patent application with ... The post AXIM Biotechnologies Files Patent on Fentanyl Neutralizing Antib... 